This Biotech Nearly Tripled Street Expectations For One Key Drug – Investor’s Business Daily


Investor's Business Daily

This Biotech Nearly Tripled Street Expectations For One Key Drug
Investor's Business Daily
... revenue grew 6% though profits sank 3.3%. On the stock market today, Biogen fell 0.6% to close at 282.96, after gaining as much as 4.3% before the open. Shares hit their highest point since April 25 while biotech stocks were generally flat early ...

and more »

Read More